切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2024, Vol. 19 ›› Issue (04) : 364 -367. doi: 10.3877/cma.j.issn.1673-9450.2024.04.017

综述

同种异体富血小板血浆临床应用的研究进展
赵芊1, 李亚坤1, 李智1,()   
  1. 1. 030032 太原,山西医科大学第三医院 山西白求恩医院医疗美容/烧伤整形科
  • 收稿日期:2024-01-24 出版日期:2024-08-01
  • 通信作者: 李智
  • 基金资助:
    山西省科技厅重点研发项目(201803D31141)

Advances in research on the clinical application of allogeneic platelet-rich plasma

Qian Zhao1, Yakun Li1, Zhi Li1,()   

  1. 1. Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Taiyuan 030032, China
  • Received:2024-01-24 Published:2024-08-01
  • Corresponding author: Zhi Li
引用本文:

赵芊, 李亚坤, 李智. 同种异体富血小板血浆临床应用的研究进展[J]. 中华损伤与修复杂志(电子版), 2024, 19(04): 364-367.

Qian Zhao, Yakun Li, Zhi Li. Advances in research on the clinical application of allogeneic platelet-rich plasma[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(04): 364-367.

自体富血小板血浆(au-PRP)是将自体血液离心后提取的血小板浓聚物,具有较强的组织修复和再生能力,在临床中已被广泛应用。但其存在使用禁忌证及相对禁忌证,且年龄或基础疾病等因素影响其使用效果。因此,研究者对同种异体富血小板血浆(al-PRP)展开了相关研究。本文对al-PRP使用可行性和安全性、优点和不足及其在临床中的应用进行综述。

Autologous platelet-rich plasma (au-PRP) is a platelet concentrate derived from autologous blood via centrifugation, which has been widely used in clinical practice owing to its pronounced tissue reparative and regenerative properties. However, its application is circumscribed by contraindications and relative contraindications, alongside potential attenuations in efficacy linked to factors such as age and basic diseases. Consequently, researchers have undertaken investigations into allogeneic platelet-rich plasma (al-PRP). This article comprehensively reviewed the feasibility and safety of al-PRP utilization, and the advantages, drawbacks and clinical applications of al-PRP.

[1]
Akbarzadeh S, McKenzie MB, Rahman MM, et al. Allogeneic platelet-rich plasma: is it safe and effective for wound repair?[J]. Eur Surg Res, 202162(1):1-9.
[2]
He M, Chen T, Lv Y, et al. The role of allogeneic platelet-rich plasma in patients with diabetic foot ulcer: current perspectives and future challenges[J]. Front Bioeng Biotechnol202210:993436.
[3]
李娇,李晓丰,李剑平.异体浓缩血小板治疗慢性难愈性创面的影响因素[J].中国组织工程研究202428(13):2114-2119.
[4]
Crowe JH, Tablin F, Wolkers WF, et al. Stabilization of membranes in human platelets freeze-dried with trehalose[J]. Chem Phys Lipids, 2003122(1-2):41-52.
[5]
杨振宇,李正发,付凌梅,等.深低温冷冻保存血小板的最佳温度及时限[J].中国组织工程研究201822(33):5368-5372.
[6]
Freitas NPP, Maior MMMS, Silva BAP, et al. In-vitro production and pre-validation of lyophilized canine platelet-rich plasma for therapeutic use[J]. Pesquisa Veterinária Brasileira202141:e06999.
[7]
何涛,耿鸿武,付涌水.输血服务蓝皮书:中国输血行业发展报告(2019)[M]. 武汉:社会科学文献出版社,2019:94-108.
[8]
Xian LJ, Chowdhury SR, Bin Saim A, et al.Concentration-dependent effect of platelet-rich plasma on keratinocyte and fibroblast wound healing[J]. Cytotherapy201517(3):293-300.
[9]
Cavallo C, Roffi A, Grigolo B, et al.Platelet-rich plasma:the choice of activation method affects the release of bioactive molecules[J]. Biomed Res Int20162016:6591717.
[10]
Sumner SM, Naskou MC, Thoresen M, et al. Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors[J]. Transfusion201757(7):1755-1762.
[11]
Du L, Miao Y, Li X, et al. A novel and convenient method for the preparation and activation of PRP without any additives: temperature controlled PRP[J]. Biomed Res Int20182018:1761865.
[12]
Stukel JRSchara KBedina-Zavec A, et al. Effect of shear stress in the flow through the sampling needle on concentration of nanovesicles isolated from blood[J]. Eur J Pharm Sci201798:17-29.
[13]
Arnoczky SP, Sheibani-Rad S. The basic science of platelet-rich plasma (PRP): what clinicians need to know[J]. Sports Med Arthrosc, 2013, 21(4):180-185.
[14]
单桂秋,施琳颖,李艳辉,等.自体富血小板血浆制备技术专家共识[J].中国输血杂志202134(7):677-683.
[15]
Rozman P. Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation[J]. Transpl Immunol2002, 10(2-3):165-181.
[16]
Marino J, Paster J, Benichou G. Allorecognition by T lymphocytes and allograft rejection[J]. Front Immunol20167:582.
[17]
姚丹,赵帆,郝岱峰,等.异体富血小板血浆免疫原性的小型猪动物实验研究[J].中华损伤与修复杂志(电子版)201813(6):439-443.
[18]
Zhang ZY, Huang AW, Fan JJ,et al. The potential use of allogeneic platelet-rich plasma for large bone defect treatment: immunogenicity and defect healing efficacy[J]. Cell Transplant201322(1):175-187.
[19]
Abouelnasr K, Hamed M, Lashen S. Enhancement of abdominal wall defect repair using allogenic platelet-rich plasma with commercial polyester/cotton fabric (Damour) in a canine model[J]. J Vet Med Sci201779(7):1301-1309.
[20]
Jeong SH, Han SK, Kim WK. Treatment of diabetic foot ulcers using a blood bank concentrate[J]. Plast Reconstr Surg2010125(3):944-952.
[21]
Raeissadat SA, Rayegani SM, Ahangar AG,et al. Efficacy of intra-articular injection of a newly developed plasma rich in growth factor (PRGF) versus hyaluronic acid on pain and function of patients with knee osteoarthritis: a single-blinded randomized clinical trial[J]. Clin Med Insights Arthritis Musculoskelet Disord201710:1179544117733452.
[22]
Etulain J. Platelets in wound healing and regenerative medicine[J]. Platelets201829(6):556-568.
[23]
田举. 年龄、疾病对富血小板血浆活性成分影响及其制备的优化[D].南方医科大学,2019.
[24]
Tyndall WA, Beam HA, Zarro C, et al.Decreased platelet derived growth factor expression during fracture healing in diabetic animals[J].Clin Orthop Relat Res2003(408):319-330.
[25]
Barrionuevo DV, Laposy CB, Abegão KG,et al.Comparison of experimentally-induced wounds in rabbits treated with different sources of platelet-rich plasma[J]. Lab Anim201549(3):209-214.
[26]
Saputro ID, Rizaliyana S, Noverta DA. The effect of allogenic freeze-dried platelet-rich plasma in increasing the number of fibroblasts and neovascularization in wound healing[J]. Ann Med Surg (Lond)202273:103217.
[27]
Kaufman RM, Djulbegovic B, Gernsheimer T,et al. Platelet transfusion: a clinical practice guideline from the AABB[J]. Ann Intern Med2015162(3):205-213.
[28]
Garraud O, Hamzeh-Cognasse H, Chalayer E,et al. Platelet transfusion in adults: an update[J]. Transfus Clin Biol202330(1):147-165.
[29]
王鹏,尹斌,苏映军,等. 长链非编码RNA介导慢性难愈性创面愈合的机制研究进展[J].中华烧伤杂志202036(8):758-761.
[30]
He M, Guo X, Li T, et al. Comparison of allogeneic platelet-rich plasma with autologous platelet-rich plasma for the treatment of diabetic lower extremity ulcers[J]. Cell Transplant202029:963689720931428.
[31]
刘鸿雁,黄文炼,李竺憬,等.同种异体富血小板血浆凝胶治疗慢性难愈性创面的疗效分析[J].中国美容整形外科杂志202132(12):741-744,755.
[32]
Liao X, Liang JX, Li SH, et al. Allogeneic platelet-rich plasma therapy as an effective and safe adjuvant method for chronic wounds[J]. J Surg Res2020246:284-291.
[33]
周婉,吴磊,周济宏,等.同种异体富血小板血浆治疗继发带状疱疹创面的探讨—附1例报道[J].中国输血杂志202336(5):436-439.
[34]
黄红梅,方勇飞,蒋天伦,等.同种异体富血小板血浆治疗白塞氏病难治性外阴溃疡1例[J].中国输血杂志201831(9):1038-1040.
[35]
Marck RE, van der Bijl I, Korsten H, et al. Activation, function and content of platelets in burn patients[J]. Platelets201930(3):396-402.
[36]
陈凤超,陈民才,颜彤彤,等.同种异体富血小板血浆对创面胶原合成的作用及其机制研究[J].中华外科杂志201755(4):303-307.
[37]
巩蜜蜜,汪海宁,吴磊,等.同种异体富血小板血浆用于慢性难愈性创面的临床研究[J].临床输血与检验202325(3):368-374.
[38]
赵露婷,方其林,唐海燕,等.自体、同种异体纯化富血小板血浆治疗兔膝骨关节炎的差异[J].中国组织工程研究202125(26):4123-4129.
[39]
Vinod E, Vinod Francis D, Manickam Amirtham S,et al. Allogeneic platelet rich plasma serves as a scaffold for articular cartilage derived chondroprogenitors[J].Tissue Cell201956:107-113.
[40]
Kanwat H, Singh DM, Kumar CD,et al. The effect of intra-articular allogenic platelet rich plasma in Dunkin-Hartley guinea pig model of knee osteoarthritis[J]. Muscles Ligaments Tendons J20187(3):426-434.
[41]
El-Gohary R, Diab A, El-Gendy H,et al.Using intra-articular allogenic lyophilized growth factors in primary knee osteoarthritis: a randomized pilot study[J].Regen Med202116(2):113-115.
[42]
Kandil MI, Tabl EA, Elhammady AS. Prospective randomized evaluation of local injection of allogeneic growth factors in plantar fasciitis[J]. Foot Ankle Int202041(11):1335-1341.
[43]
Jo CH, Lee SY, Yoon KS,et al. Allogenic pure platelet-rich plasma therapy for rotator cuff disease: a bench and bed study[J]. Am J Sports Med201846(13):3142-3154.
[1] 王鹏, 肖厚安, 贾赤宇. 不同因素调控巨噬细胞极化在慢性难愈性创面中的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 454-459.
[2] 贾蔓箐, 卞婧, 周业平. 对小剂量胰岛素局部注射促进脂肪干细胞移植成活及改善糖尿病创面愈合临床观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(04): 312-316.
[3] 谭谦, 蒋亚楠. 皮瓣在慢性难愈性创面治疗中的应用[J]. 中华损伤与修复杂志(电子版), 2017, 12(06): 414-420.
[4] 廖新成, 郭光华. 慢性难愈性创面的分类鉴别及临床评估[J]. 中华损伤与修复杂志(电子版), 2017, 12(04): 303-305.
[5] 晁生武, 李毅, 刘宏, 刘全, 唐才良. 高原地区慢性难愈性创面感染常见致病菌监测及耐药性分析[J]. 中华损伤与修复杂志(电子版), 2017, 12(02): 109-112.
阅读次数
全文


摘要